Results 281 to 288 of about 5,569,467 (288)

Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Nature, 2007
Yan Zheng, D. Danilenko, P. Valdez, I. Kasman, J. Eastham‐Anderson, Jianfeng Wu, W. Ouyang   +6 more
semanticscholar   +1 more source

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

BioDrugs, 2020
Ahmed M. Almradi, J. Hanžel, R. Sedano, C. Parker, B. Feagan, Christopher Ma, V. Jairath   +6 more
semanticscholar   +1 more source

Targeting IL-23 for axial disease in PsA

Nature Reviews Rheumatology, 2021
openaire   +2 more sources

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

Nature Medicine, 2015
M. Teng, E. Bowman, J. McElwee, M. Smyth, J. Casanova, A. Cooper, D. Cua   +6 more
semanticscholar   +1 more source

The IL-23–IL-17 pathway as a therapeutic target in axial spondyloarthritis

Nature Reviews Rheumatology, 2019
J. Sieper, D. Poddubnyy, P. Miossec
semanticscholar   +1 more source

IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

Nature reviews: Gastroenterology & hepatology, 2018
A. Moschen, H. Tilg, T. Raine
semanticscholar   +1 more source

IL-23 Antagonists

openaire   +1 more source

IL-17 and IL-23

2012
openaire   +1 more source